Martine Rothblatt

2018

In 2018, Martine Rothblatt earned a total compensation of $16M as Chairman and Chief Executive Officer at United Therapeutics, a 57% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,021,250
Option Awards$12,796,803
Salary$1,208,447
Other$9,800
Total$16,036,300

Rothblatt received $12.8M in option awards, accounting for 80% of the total pay in 2018.

Rothblatt also received $2M in non-equity incentive plan, $1.2M in salary and $9.8K in other compensation.

Rankings

In 2018, Martine Rothblatt's compensation ranked 276th out of 14,244 executives tracked by ExecPay. In other words, Rothblatt earned more than 98.1% of executives.

ClassificationRankingPercentile
All
276
out of 14,244
98th
Division
Manufacturing
94
out of 5,758
98th
Major group
Chemicals And Allied Products
31
out of 2,119
99th
Industry group
Drugs
26
out of 1,808
99th
Industry
Pharmaceutical Preparations
18
out of 1,382
99th
Source: SEC filing on April 29, 2019.

Rothblatt's colleagues

We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2018.

2018

Michael Benkowitz

United Therapeutics

Chief Operating Officer

2018

Paul Mahon

United Therapeutics

General Counsel

2018

James Edgemond

United Therapeutics

Chief Financial Officer

News

In-depth

You may also like